Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3700
-0.0100 (-2.63%)
Jun 26, 2026, 3:55 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 109.49 million as of June 26, 2026. Its market cap has increased by 123.20% in one year.
Market Cap
109.49M
Enterprise Value
102.62M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 109.49M, an increase of 157.57%. That is a compound annual growth rate of 19.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 109.49M | -5.36% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 121.80M |
| Actinogen Medical | 117.05M |
| Recce Pharmaceuticals | 115.67M |
| Dimerix | 114.08M |
| LTR Pharma | 101.80M |
| Nyrada | 97.98M |
| Paradigm Biopharmaceuticals | 84.07M |
| Arovella Therapeutics | 79.78M |